Latest Research News from the Foundation for Women's Cancer and Society of Gynecologic Oncology

Article

An update from the Foundation for Women's Cancer and Society of Gynecologic Oncology

Hear from Dr. Anil Sood, Foundation for Women's Cancer Research Chairman, and Carol Brown, 2014 Society of Gynecologic Oncology Program Chair, about research of interest to women and the public presented at the 2014 SGO Annual Meeting on Women's Cancer. (https://www.youtube.com/watch?v=KKB63TGlOcQ&feature=youtu.be)

Recent Videos
Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC in an interview with oncology nursing news
Anne M. Reb, PhD, NP, discussing a nurse-led intervention for fear of cancer recurrence.
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
Elizabeth Burton in an interview with Oncology Nursing News
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
breast on yellow background

Cancer Vaccine Sparks Immune Response in TNBC

Jordyn Sava
November 25th 2024
Article

Most patients with triple-negative breast cancer experienced a protocol-defined immune response with an investigational vaccine, phase 1 data showed.

The Vitals

What New Cancer Drugs Were Approved in 2023?

Lindsay Fischer
January 1st 2024
Podcast

In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

gynecologic system on light blue background

Consider BRCA, HRD Status Before Deciding on a PARP Inhibitor for Ovarian Cancer

Ashling Wahner
November 23rd 2024
Article

PARP inhibitors have changed the way we think about [managing] ovarian cancer,” Whitney Goldsberry, MD, said

The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
December 14th 2023
Podcast

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

FDA on a blue background

FDA OKs New Drug Label for Fludarabine Phosphate for CLL Treatment

Caroline Seymour
November 22nd 2024
Article

The FDA approved an updated drug label for fludarabine phosphate for the treatment of B-cell chronic lymphocytic leukemia.

mental health

Palliative Care Is Underutilized, May Boost Mental Health in Pancreatic Cancer

Gina Mauro
November 21st 2024
Article

Approximately one-third of patients with pancreatic cancer and anxiety had a palliative care consultation, data showed.

© 2024 MJH Life Sciences

All rights reserved.